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Abstract
Motivation: Accurate identification of peptides binding to specific Major Histocompatibility Complex Class II (MHC-II)
molecules is of great importance for elucidating the underlying mechanism of immune recognition, as well as for
developing effective epitope-based vaccines and promising immunotherapies for many severe diseases. Due to extreme
polymorphism of MHC-II alleles and the high cost of biochemical experiments, the development of computational methods
for accurate prediction of binding peptides of MHC-II molecules, particularly for the ones with few or no experimental data,
has become a topic of increasing interest. TEPITOPE is a well-used computational approach because of its good
interpretability and relatively high performance. However, TEPITOPE can be applied to only 51 out of over 700 known HLA
DR molecules.
Method: We have developed a new method, called TEPITOPEpan, by extrapolating from the binding specificities of HLA DR
molecules characterized by TEPITOPE to those uncharacterized. First, each HLA-DR binding pocket is represented by amino
acid residues that have close contact with the corresponding peptide binding core residues. Then the pocket similarity
between two HLA-DR molecules is calculated as the sequence similarity of the residues. Finally, for an uncharacterized HLA-
DR molecule, the binding specificity of each pocket is computed as a weighted average in pocket binding specificities over
HLA-DR molecules characterized by TEPITOPE.
Result: The performance of TEPITOPEpan has been extensively evaluated using various data sets from different viewpoints:
predicting MHC binding peptides, identifying HLA ligands and T-cell epitopes and recognizing binding cores. Among the
four state-of-the-art competing pan-specific methods, for predicting binding specificities of unknown HLA-DR molecules,
TEPITOPEpan was roughly the second best method next to NETMHCIIpan-2.0. Additionally, TEPITOPEpan achieved the best
performance in recognizing binding cores. We further analyzed the motifs detected by TEPITOPEpan, examining the
corresponding literature of immunology. Its online server and PSSMs therein are available at http://www.biokdd.fudan.edu.
cn/Service/TEPITOPEpan/.
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Introduction
Major histocompatibility complex (MHC) molecules play a
crucial role in the adaptive immune system mediated by T cells
[1], in which peptide fragments derived from pathogens first bind
to MHC molecules and are then presented on the surface of a cell
for recognition by T cell receptor (TCR). This process enables the
immune system to detect the presence of foreign pathogens, and
thus induce the immune response to eliminate invading pathogens.
Accurate identification of peptides that bind to specific MHC
molecules is therefore of great importance for the following points:
1) understanding the underlying mechanism of immune recogni-
tion; 2) developing effective peptide-based vaccines against
infectious diseases; and 3) promising immunotherapies for allergy,
autoimmunity, and cancers [2]. In contrast to biochemical
experiments that takes lots of expenses and time, computational
approaches for predicting MHC binding peptides have received
extensive attentions [3,4]. They have been utilized to select a small
number of promising candidate epitopes for further experimental
verification [5].
According to their different roles in the immune system, MHC
molecules can be divided into two major classes: MHC class I
(MHC-I) and MHC class II (MHC-II). MHC-I molecules sample
and bind intracellular antigenic peptides (normally nine amino
acids), and present them to cytotoxic T lymphocytes (CTL) to
stimulate cellular immunity, while MHC-II molecules sample and
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which are presented to helper T lymphocytes [1]. An MHC
molecule has the binding groove of nine pockets (or polymorphic
cavities), while a binding peptide has a binding core, usually a
nonamer, fitted to the binding groove, where one residue of the
binding core corresponds to one pocket. The binding groove of
MHC-I is closed at both ends, whereas that of MHC-II is open at
both ends, which leads to the flexibility in the length and binding
core location of MHC-II binding peptide. This difference makes
the problem of predicting peptides binding to MHC-II more
challenging than that to MHC-I [6–9]. In fact, the current state-
of-the-art performance of this problem for MHC-I reaches an
AUC (Area Under the ROC Curve) of between 0.85 and 0.95,
whereas the AUC of the same problem for MHC-II stays roughly
between 0.70 and 0.85 [10]. In this work, we focus on predicting
MHC-II binding peptides, a more challenging problem.
MHC molecules are highly polymorphic, and there are
thousands of MHC allelic variants. For human beings, MHC is
known as Human Leukocyte Antigens (HLA), which involves three
types of HLA class II molecules: DP, DQ and DR [1]. By June
2011, up to 1457 HLA class II alleles are collected in IMGT/HLA
[11]. Each HLA-II molecule consists of two types of domains, a (A)
and b (B). For example, the most widely studied HLA-DR
molecules have DRA and DRB, corresponding to a and b domains,
respectively. While DRB is diverse, DRA is almost identical, by
which the binding specificities of DR molecules are mainly
determined by DRB. Thus, hereafter, the binding specificity of a
DRB allele indicates that of the corresponding HLA-DR.
Each MHC molecule has its own binding specificity, meaning
that a set of peptides binding to an MHC molecule can be
different from those to another MHC molecule. Thus, conven-
tional prediction models are allele-specific, where for a target
MHC-II molecule, a model is trained by peptide sequences
binding to this molecule to predict the specificity of an arbitrary
given peptide [12–17]. In general they need 100–200 quantitative
peptide-binding measurements for each target molecule [14].
However, the number of MHC-II molecules which can have a
large number of binding peptides is very small. For example,
IEDB (Jun. 2011), the largest database of MHC binding peptides
[18], contains only around 30 HLA-II molecules for which a few
hundred peptides have experimentally measured binding affinity.
This means that overwhelmingly most MHC-II molecules have
very few or even no binding data, which cannot be handled by
allele-specific methods. To address this problem, so-called pan-
specific methods which can predict the specificity of peptides
binding to MHC molecules with almost no binders have been
developed first for MHC-I [19] and then for MHC-II [20]. These
pan-specific methods take into account both peptide sequences
and MHC-peptide contact, which is represented by MHC residues
being in contact with each binding peptide. The pioneering pan-
specific method for HLA-I is MULTIPRED [21], which shares
binding data within HLA-I supertype (a group of MHC molecules
sharing similar binding specificities [22]) and trained supertype-
specific models to cover many HLA-I molecules.
The first pan-specific method for MHC-II molecules is
TEPITOPE, which uses position specific scoring matrix (PSSM)
[23]. TEPITOPE generates 51 PSSMs, which cover 51 different
HLA-DR alleles. These PSSMs are derived from 11 HLA DRB
alleles: DRB1*01:01, DRB1*03:01, DRB1*04:01, DRB1*04:02,
DRB1*04:04, DRB*07:01, DRB1*08:01, DRB1*11:01, DRB1*
13:02, DRB1*15:01 and DRB5*01:01 (the alleles in this paper are
represented in current HLA allele nomenclature [24]). There are
other five pan-specific methods: MHCIIMulti [25], NetMHCII-
pan-1.0 [26], NetMHCIIpan-2.0 [27], MultiRTA [28] and SIADT
(ShiftInvariantAdaptiveDoubleThreading)[29].MHCIIMultiisa
kernel based method, in which the binding specificity of a target
MHC with no binding data can be predicted by using binding data
of related MHC alleles. Both NetMHCIIpan-1.0 and NetMHCII-
pan-2.0 use ANN (Artificial Neural Network) with co-encoding of
both binding peptides and pocket sequences of MHC-II molecules
as input. The difference between NetMHCIIpan-1.0 and NetMH-
CIIpan-2.0 lies in the identification of the peptide binding core. In
NetMHCIIpan-1.0, the core is pre-identified using SMM-align
[14], whereas in NetMHCIIpan-2.0, the identification of binding
core and training weights of ANN are both done in the ANN
learning process. MultiRTA considers all possible peptide binding
core configurations, and the MHC-peptide binding affinity is
computed as a weighted average over the binding affinities of all
possible configurations. SIADT is based on threading, which has
been used for predicting protein 3D structure. Note that all these
methods except SIADT have publicly available implementations.
Although TEPITOPE is not necessarily the best in performance
among them, TEPITOPE can provide prediction rules which could
be easily understood, and thus TEPITOPE has earned wide
popularity among biologists [10]. However, a drawback of
TEPITOPE is that only 51 DR molecules are covered out of over
700 known DR molecules, which greatly limits its usability.
To overcome this problem, keeping the advantage of TEPI-
TOPE in rule comprehensibility, we propose a new method,
TEPITOPEpan, which can extrapolate from the HLA-DR
molecules with known binding specificities (PSSMs) in TEPI-
TOPE to the HLA-DR molecules with unknown binding
specificities based on pocket similarity. The procedure of
TEPITOPEpan for a target HLA is as follows: using the MHC-
II HLA-peptide complex structure in Protein Data Bank (PDB),
pockets are first represented by the polymorphic residues that have
close contact with one or more residues of binding core. Then the
pocket similarity between two HLA molecules is computed by the
sequence similarity of the corresponding HLA residues. For an
uncharacterized HLA-DR molecule, the binding specificity of
each pocket was computed as a weighted average of pocket
binding specificities over HLA-DR molecules characterized by
TEPITOPE. The idea of TEPITOPEpan comes from PickPocket
[30], a pan-specific method for MHC-I, which also derived the
binding specificities (PSSM) of a novel MHC molecule from a
library of specificity matrices (PSSMs). A clear difference between
TEPITOPEpan and PickPocket is that TEPITOPEpan uses the
library of specificity matrices obtained in TEPITOPE, while
PickPocket generates that from binding data directly.
We evaluated the performance of TEPITOPEpan extensively
using a variety of datasets, assuming different types of settings, and
comparing with the state-of-the-art pan-specific methods. We are
especially interested in the performance on uncharaterized MHC
molecules, which is the main target of pan-specific methods.
Experimental results showed that, for predicting the binding
specificities of novel HLA DR molecules, TEPITOPEpan achieved
roughly the second best performance next to NetMHCIIpan-2.0,
which however cannot show any comprehensible rules. In
particular, TEPITOPEpan outperformed competing methods on
predicting the location of the binding core. We further checked the
obtained rules of TEPITOPEpan by using sequence logos, which
showed that primary anchors are well consistent with the literature.
Materials and Methods
Data
We generated eight datasets: Nielsen-Set1, Nielsen-Set2, Lin-
Set3, Epan-Set4, Bordner-Set5, SYF-Set6, EIEDB-Set7 and
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MHC binding peptides, endogenously presented MHC ligands, T-
cell epitopes, and those obtained from HLA-peptide complexes.
We used Nielsen-Set1 to select suitable parameters in TEPITO-
PEpan, while the remaining seven were used for extensive
evaluation, such as comparison with the state-of-the-art pan-
specific methods, including NetMHCIIpan-2.0, NetMHCIIpan-
1.0 and MultiRTA.
Nielsen-Set1 which was obtained from [14] has 4,603
peptides with quantitative binding measures covering 14 HLA-
DR alleles.
Nielsen-Set2 was from [27] and comprises 33,931 binding
peptides of 24 HLA-DRB alleles.
Lin-Set3 has 103 overlapping peptides for each of 7 common
HLA-DR alleles that were derived from four distinct antigens [9].
Lin-Set3 was downloaded from Dana-Farber Repository for
Machine Learning in Immunology (DFRMLI) [31].
Epan-Set4 has 2,412 peptides associated with 14 novel HLA-
DRB alleles (including 2 alleles in Nielsen-Set2 though). Epan-Set4
was generated by us for assessing the predictive performance of
competing methods for new alleles, as follows: We first focused on
HLA-DRB alleles which were not in the 14 alleles of Nielsen-Set1
and the 11 alleles for TEPITOPE. We then retrieved peptides
binding to these HLA-DRB alleles from IEDB (Mar. 2011) [18].
We, for the two alleles (DRB1*03:02 and DRB1*12:01) in Nielsen-
Set2, discarded peptides sharing at least nine consecutive residues
with a peptide binding to either of the two alleles in Nielsen-Set2.
Finally, we kept HLA-DRB alleles with more than 40 peptides, to
remove datasets with a small size. Epan-Set4 can be downloaded
from TEPITOPEpan website.
Bordner-Set5 was taken from [28] and has 127 peptides
restricted to HLA-DRB1*13:01. Note that Bordner-Set5 is a
subset of peptides binding to HLA-DRB1*13:01 in Epan-Set4.
SYF-Set6 has 1,164 ligands restricted to 28 HLA-DR alleles,
from SYFPEITHI (Nov. 2009) [32].
EIEDB-Set7 comprises 1,325 T-cell epitopes restricted to 42
HLA-DR alleles, being retrieved from IEDB (Jun. 2010) [18].
SYF-Set6 as well as EIEDB-Set7 were prepared to evaluate the
competing methods by using HLA-II ligands and T-cell epitopes.
SYF-Set6 and EIEDB-Set7 are two datasets in [27]. In these two
datasets, all ligands and epitopes in Nielsen-Set2 were eliminated.
EpanCore-Set8 has 20 distinct 3D complex structures of
peptide binding to 7 HLA-DR molecules that have known binding
cores and are obtained from PDB, 15 of which are taken from
[16]. EpanCore-Set8 was used to evaluate TEPITOPEpan in
terms of identifying the peptide binding core.
Method
TEPITOPE has a library of 11 PSSMs. One PSSM is a 2069
matrix where nine binding specificity vectors correspond to nine
pockets. Each of the 11 PSSMs corresponds to one of 11 known
DRB alleles. TEPITOPEpan uses this library to generate a PSSM
for an arbitrary HLA-DRB allele. In a generated PSSM, each
vector is a weighted average of binding specificity vectors of the
corresponding pocket over 11 DRB alleles. The weight can be
computed by pocket sequence similarity. Thus the assumption
behind TEPITOPEpan is that different alleles have similar
binding preferences for one pocket (e.g. P1) if their MHC amino
acids for the pocket are similar. The procedure of TEPITOPEpan
has the following three steps:
Step 1: Generating pseudosequences of MHC binding
pockets. We first represent MHC binding pockets by using the
3D structure of MHC-II HLA-peptide complexes. Table 1 shows
32 HLA-peptide complexes which are retrieved from PDB. Note
that Table 1 is the largest set of HLA-peptide complexes ever used
in the literature. Each binding peptide of the 32 complexes has
nine core residues (being in bold in Table 1), which are
accommodated in 9 pockets labeled by P1, ..., P9. We can then
represent each pocket by several MHC residues, which we call
‘‘contact residues’’, which are in contact with the corresponding
(binding core) residue. Here for each binding core residue we
define a MHC residue as a contact residue if the distance between
these two residues is within 4A [30]. MHC sequences are retrieved
from IMGT/HLA and then aligned. For each of the 32
complexes, we extract contact residues for each pocket (shown in
Table S1), and then, for each pocket, use a union of contact
residues over 32 complexes. Table 2 shows positions of contact
residues for each pocket. We can generate a pseudosequence of
each pocket for any HLA-DR allele by using a sequence of amino
acids at the positions of the corresponding pocket in Table 2.
Table 1. Available X-ray structures of MHC class II HLA-
peptide complexe.
PDB ID HLA Allele Peptide Sequence
1AQD DRB1*01:01 VGSDWRFLRGYHQYA
1PYW DRB1*01:01 XFVKQNAAALX
1KLG DRB1*01:01 GELIGILNAAKVPAD
2FSE DRB1*01:01 AGFKGEQGPKGEPG
1KLU DRB1*01:01 GELIGTLNAAKVPAD
1SJH DRB1*01:01 PEVIPMFSALSEG
1SJE DRB1*01:01 PEVIPMFSALSEG
1T5W DRB1*01:01 AAYSDQATPLLLSPR
1T5X DRB1*01:01 AAYSDQATPLLLSPR
2IAN DRB1*01:01 GELIGTLNAAKVPAD
2IAM DRB1*01:01 GELIGILNAAKVPAD
2IPK DRB1*01:01 XPKWVKQNTLKLAT
1FYT DRB1*01:01 PKYVKQNTLKLAT
1R5I DRB1*01:01 PKYVKQNTLKLAT
1HXY DRB1*01:01 PKYVKQNTLKLAT
1JWM DRB1*01:01 PKYVKQNTLKLAT
1JWS DRB1*01:01 PKYVKQNTLKLAT
1JWU DRB1*01:01 PKYVKQNTLKLAT
1LO5 DRB1*01:01 PKYVKQNTLKLAT
2ICW DRB1*01:01 PKYVKQNTLKLAT
2OJE DRB1*01:01 PKYVKQNTLKLAT
2G9H DRB1*01:01 PKYVKQNTLKLAT
1A6A DRB1*03:01 PVSKMRMATPLLMQA
1J8H DRB1*04:01 PKYVKQNTLKLAT
2SEB DRB1*04:01 AYMRADAAAGGA
1BX2 DRB1*15:01 ENPVVHFFKNIVTPR
1YMM DRB1*15:01 ENPVVHFFKNIVTPRGGSGGGGG
2Q6W DRB3*01:01 AWRSDEALPLGS
3C5J DRB3*02:01 QVIILNHPGQISA
1FV1 DRB5*01:01 NPVVHFFKNIVTPRTPPPSQ
1H15 DRB5*01:01 GGVYHFVKKHVHES
1ZGL DRB5*01:01 VHFFKNIVTPRTPGG
The table shows complex structures retrieved from PDB. The columns in the
table give PDB ID, HLA-DR restriction and bound peptide (binding core
highlighted in bold).
doi:10.1371/journal.pone.0030483.t001
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between alleles. We compute the similarity between two
pseudosequences (of query allele q and allele l in the library of
TEPITOPE) using the approach proposed in PickPocket [30].
Assuming that pocket p has n positions, for pocket p, from two
pseudosequence sq,p(~sq,p(1)...sq,p(n)) of query allele q and
pseudosequence sl,p(~sl,p(1)...sl,p(n)) of allele l, we can first
compute similarity value Blosump(q,l) at pocket p by just summing
up over the similarities of all positions.
Blosump(q,l)~
X n
i~1
Blosum62(sq,p(i),sl,p(i)), ð1Þ
where Blosum62(sq,p(i),sl,p(i)) is the Blosum62 similarity score
between two amino acids, sq,p(i) and sl,p(i). We then have the
normalized similarity Sp(q,l) at pocket p as follows:
Sp(q,l)~maxf0,
Blosump(q,l)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Blosump(q,q)   Blosump(l,l)
p gð 2Þ
where Sp(q,l) is 1 for two identical pseudosequences and 0 for
totally distinctive pseudosequences. We can then compute the
weight wp(ljq) between q and l at pocket p, by using Sp(q,l) as
follows:
wp(ljq)~
Sp(q,l)
a
P
k
Sp(q,k)
a ð3Þ
where k takes over 11 DRB alleles in the library of TEPITOPE, a
is the parameter taking a positive value only, which adjusts the
contribution of alleles. A larger a will assign lower weights to
dissimilar alleles, by which similar alleles will be pronounced more.
Step 3: Computing PSSM. For each pocket p, allele l in the
library has binding specificity vector vp(l) (i.e. p-th column of
PSSM). We then compute binding specificity vector vp(q) of query
allele q by using vp(l) and wp(ljq) as a weighted average over all
alleles in the library as follows:
vp(q)~
X
l
wp(ljq)vp(l) ð4Þ
Finally we can have PSSM M(q) for query MHC allele q
naturally as follows:
M(q)~(v1(q)...v9(q)) ð5Þ
In this manner, we can generate a PSSM matrix for each of over
700 HLA-DR alleles with known sequences by considering each
allele as a query allele. Note that actually we used only 35 pockets
(vectors) in total of 11 HLA-DR alleles, instead of all 99 (=9
pockets|11 alleles) pockets. This is because that pockets 5 and 8
are not used in the PSSMs of TEPITOPE, and some alleles share
identical binding specificities on some pockets.
Results
We first used Nielsen-Set1 to determine the value of a and then
used the other seven datasets to compare the performance of
TEPITOPEpan with those of NetMHCIIpan-2.0, NetMHCII-
pan-1.0, MultiRTA and TEPITOPE. We obtained results of
NetMHCIIpan-2.0 and NetMHCIIpan-1.0 by running their freely
available packages and those of MultiRTA from the outputs of the
web server of MultiRTA (http://bordnerlab.org/MultiRTA). We
used AUC (Area under the ROC (Receiver Operator Character-
istic) Curve) to measure the performance. We further used the
one-tailed per-allele binomial test (excluding ties) to examine
statistical significance of the performance difference between two
methods, regarding those with p-values of less than 0.05 as
significant cases.
Determining a
Table 3 shows the AUC of TEPITOPEpan on Nielsen-Set1
with different a, which was set from 1 to 50. Note that for each
value of a, we adopted the same value for all HLA-DRB alleles. In
this table, 1-KNN means the result of using only the most similar
pocket specificity vector in the library of TEPITOPE. We
observed that TEPITOPEpan performs better under a of 5 to
30, reaching the best average AUC of 0.739 in cases of a~5 or 10.
Table 3 shows that TEPITOPEpan performs better with a~10
than with a~5 in 8 of the total 14 alleles. In addition
TEPITOPEpan with a~10 performed better than 1-KNN, being
statistically significant (binomial test, p-valuev0.05) and outper-
formed TEPITOPE in 8 out of 11 alleles covered by TEPITOPE.
We thus keep a~10 throughout all other experiments in this work.
Evaluation by Nielsen-Set2
Table 4 shows the comparison result on 10 alleles in Nielsen-
Set2 (which has 24 HLA-DRB alleles, but peptide data of the
other 14 alleles are significantly overlapped with training data of
NetMHCIIpan-1.0 and MultiRTA). This table shows that
TEPITOPEpan was the second best method with an average
AUC of 0.763. In fact TEPITOPEpan outperformed MultiRTA
in all 10 alleles and NetMHCIIpan-1.0 in 9 out of 10 alleles, both
being statistically significant (binomial test, p-valueƒ0.01). We
note that the results of the best method, i.e. NetMHCIIpan-2.0,
are not necessarily comparable, since exceptionally they are
directly taken from [27], in which results were obtained by using
LOO (Leave-one-allele-out, where the binding data of the other
23 alleles were used for training and the remaining one for testing).
This means that the AUC of NetMHCIIpan-2.0 will be much
lower if trained by 14 common alleles only, like NetMHCIIpan-
1.0 and MutliRTA. Further note that TEPITOPEpan is robust,
being unaffected by training data.
Table 2. The HLA-DR amino acid residue positions of each
pockets in TEPITOPEpan profile.
Pocket Residue positions
P1 82 85 86 89
P2 77 78 81 82
P3 78
P4 11 13 26 28 70 71 74 78
P5 11 13 28 70 71 74
P6 11 13 28 30 61 71
P7 11 28 30 47 61 67 70 71
P8 60 61
P 9 93 03 75 76 06 1
The first column gives nine pockets (P1 to P9). The second column shows
corresponding residue positions in contact with each pocket.
doi:10.1371/journal.pone.0030483.t002
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Table 5 shows the comparison result on 7 HLA-DRB alleles in
Lin-Set3. TEPITOPEpan achieved the comparable accuracy with
TEPITOPE as well as NetMHCIIpan-1.0 and MultiRTA.
Specifically, TEPITOPEpan outperformed TEPITOPE in 5 out
of 7 alleles (with one tie), and outperformed both NetMHCIIpan-
1.0 and MulitRTA in 4 out of 7 alleles.
Evaluation by Epan-Set4
Table 6 shows the comparison result on Epan-Set4, which is our
original, well-qualified dataset. Again TEPITOPEpan performed
the second best, next to NetMHCIIpan-2.0, on average, and
outperformed TEPITOPE, MultiRTA and NetMHCIIpan-1.0.
Concretely, out of 14 alleles, TEPITOPEpan outperformed
MultiRTA in 9, NetMHCIIpan-1.0 in 7, and NetMHCIIpan-
2.0 in 6 alleles, which are all in 12 alleles not covered by Nielsen-
Set2.
Evaluation by Bordner-Set5
The comparison result on Bordner-Set5 (HLA-DRB1*13:01)
shows that TEPITOPEpan achieved the highest AUC value of
0.833, being followed by MutliRTA (AUC of 0.761), NetMHCII-
pan-1.0 (AUC of 0.719) and NetMHCIIpan-2.0 (AUC of 0.690).
Evaluation by Peptide Binding Motifs
We explored the difference of four competing methods:
TEPITOPEpan, MultiRTA, NetMHCIIpan-1.0 and NetMHCII-
pan-2.0, by visualizing binding motifs of alleles as sequence logos
[33], using the following procedure: We first generated 100,000
peptides from SWISS-PROT randomly. Then, for each of the
Table 3. Performance of TEPITOPEpan with different alphas in terms of AUC.
Allele Count a~1 a~2 a~3 a~5 a~10 a~20 a~30 a~50 1-KNN TEPITOPE
DRB1*01:01 1203 0.622 0.635 0.642 0.648 0.651 0.650 0.650 0.650 0.650 0.650
DRB1*03:01 474 0.591 0.639 0.689 0.724 0.733 0.729 0.728 0.728 0.729 0.727
DRB1*04:01 457 0.745 0.757 0.764 0.771 0.773 0.767 0.764 0.759 0.756 0.756
DRB1*04:04 168 0.819 0.832 0.836 0.842 0.844 0.843 0.841 0.839 0.838 0.837
DRB1*04:05 171 0.748 0.762 0.770 0.783 0.792 0.794 0.799 0.798 0.795 0.795
DRB1*07:01 310 0.753 0.772 0.773 0.770 0.767 0.767 0.767 0.767 0.766 0.766
DRB1*08:02 174 0.771 0.781 0.793 0.797 0.794 0.792 0.791 0.790 0.790 0.788
DRB1*09:01 117 0.731 0.724 0.715 0.702 0.696 0.689 0.688 0.689 0.686 0.644
DRB1*11:01 359 0.691 0.699 0.704 0.707 0.714 0.721 0.723 0.723 0.723 0.723
DRB1*13:02 179 0.725 0.735 0.744 0.745 0.743 0.736 0.735 0.735 0.736 0.737
DRB1*15:01 365 0.717 0.727 0.734 0.735 0.731 0.731 0.730 0.730 0.730 0.730
DRB3*01:01 102 0.640 0.700 0.734 0.754 0.731 0.707 0.700 0.663 0.606 0.673
DRB4*01:01 181 0.698 0.705 0.714 0.725 0.731 0.741 0.742 0.743 0.744 0.718
DRB5*01:01 343 0.626 0.638 0.644 0.645 0.651 0.652 0.651 0.651 0.651 0.652
Average 4603 0.706 0.722 0.732 0.739 0.739 0.737 0.737 0.733 0.729 0.728
The highest value in each row of columns for a is highlighted in bold. 1-KNN means the result of using only specificity vector(s) in the library with highest similarity to
derive PSSM.
doi:10.1371/journal.pone.0030483.t003
Table 4. AUC on Nielsen-Set2.
Allele Count Binder NetMHCIIpan2.0 NetMHCIIpan-1.0 MultiRTA TEPITOPE TEPITOPEpan
DRB1*03:02 148 44 0.759 0.688 0.549 0.602
DRB1*08:06 118 91 0.902 0.703 0.652 0.870 0.886
DRB1*08:13 1370 455 0.666 0.763 0.712 0.746 0.768
DRB1*08:19 116 54 0.813 0.677 0.630 0.714
DRB1*12:01 117 81 0.798 0.587 0.620 0.832
DRB1*12:02 117 79 0.879 0.660 0.663 0.842
DRB1*14:02 118 78 0.846 0.713 0.672 0.725
DRB1*14:04 30 16 0.679 0.571 0.563 0.683
DRB1*14:12 116 63 0.897 0.797 0.688 0.804
DRB3*03:01 160 70 0.765 0.739 0.729 0.771
Average 0.800 0.690 0.683 0.763
The highest values for each allele are highlighted in bold. Results of NetMHCIIpan-2.0 are obtained by leave-one-(allele)-out (LOO) experiment over original 24 alleles in
[27].
doi:10.1371/journal.pone.0030483.t004
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and selected the top 1% peptides in scores to draw sequence logos,
as described in [14]. Figure 1 shows the sequence logos (binding
motifs) of the four methods on four alleles DRB1*04:02,
DRB1*11:01, DRB1*12:01 and DRB1*13:01 obtained in this
manner (see Figure S1 and S2 for more sequence logos of other 12
HLA-DR alleles). In Figure 1, the height in a column indicates the
relative information content of the corresponding pocket in the
motif, and the height of each letter stands for the amino acid
frequency in the corresponding pocket. TEPITOPEpan has
already achieved a good performance on these four alleles. In
addition, the sequence logos by TEPITOPEpan were consistent
with known binding motifs in SYFPEITHI [32] and the HLA
FactsBook [34]. We first note that all methods agreed that the
information content of the first pocket is high and amino acids
preferred in this pocket are relatively fixed, indicating that the first
pocket, i.e. P1, must be a primary anchor. In addition, most methods
suggested that P4, P6, P7 and P9 are primary anchors. Meanwhile,
we could observe obvious differences in primary anchors among
sequence logos by these four methods. For example, P5 was
identified as a primary anchor by MultiRTA, while P5 and P8
were not thought as primary anchors in TEPITOPEpan at all.
More specifically, in SYFPEITHI, the motif of DRB1*04:02 is
[VILM]xx[YFWILMRN]x[NQSTK][RKHNQP]x[DEHLNQ
RSTYCILMVHA]. The sequence logos of most methods were
consistent with this motif at major primary anchors, such as P1
and P6, while amino acids by competing methods were very
different from each other at P4. At P4, TEPITOPEpan
suggested arginine (R) and phenylalanine (F), which were the
most consistent with the motif in SYFPEITHI. Similarly, the
binding motif of DRB1*1301 in SYFPEITHI is [ILV]xx[LV-
MAWY]x[RK]xx[YFAST], and [IVF]xx[YWLVAM]x[RK]x-
Table 5. AUC on Lin-Set3.
Allele Count Binder NetMHCIIpan-2.0 NetMHCIIpan-1.0 MultiRTA TEPITOPE TEPITOPEpan
DRB1*01:01 103 15 0.883 0.846 0.817 0.892 0.892
DRB1*03:01 103 18 0.716 0.668 0.757 0.695 0.680
DRB1*04:01 103 8 0.845 0.814 0.696 0.754 0.782
DRB1*07:01 103 10 0.878 0.852 0.781 0.740 0.741
DRB1*11:01 103 39 0.883 0.820 0.819 0.824 0.826
DRB1*13:01 103 11 0.728 0.715 0.686 0.715 0.716
DRB1*15:01 103 11 0.838 0.790 0.689 0.659 0.661
Average 0.824 0.786 0.749 0.754 0.757
The highest value for each allele is highlighted in bold. According to Nielsen et al. [27], for DRB1*01:01, 04:01, 07:01 and 15:01, binding threshold is set to 100 nM, and
threshold is set to 1000 nM for the rest when calculating the AUC.
doi:10.1371/journal.pone.0030483.t005
Table 6. AUC on Epan-Set4.
Allele Count Binder NetMHCIIpan-2.0 NetMHCIIpan-1.0 MulitRTA TEPITOPE TEPITOPEpan
DRB1*01:02 92 62 0.746 0.785 0.749 0.762 0.758
DRB1*01:03 52 41 0.772 0.756 0.772 0.867
DRB1*03:02 88 44 0.840 0.775 0.733 0.823
DRB1*04:03 63 14 0.678 0.659 0.611 0.762
DRB1*04:06 92 37 0.486 0.557 0.519 0.501
DRB1*11:02 65 30 0.774 0.738 0.591 0.723 0.738
DRB1*11:03 64 27 0.791 0.623 0.585 0.726
DRB1*11:04 73 34 0.737 0.639 0.618 0.664 0.654
DRB1*12:01 719 446 0.740 0.721 0.673 0.659
DRB1*13:01 302 132 0.494 0.516 0.567 0.637 0.623
DRB1*14:01 43 33 0.676 0.761 0.809 0.785
DRB1*15:02 47 21 0.888 0.762 0.777 0.740 0.742
DRB1*16:01 56 17 0.814 0.793 0.789 0.644
DRB3*02:02 656 318 0.806 0.732 0.680 0.686
Average 0.732 0.701 0.677 0.712
Average (Tepitope
alleles)
0.728 0.688 0.661 0.705 0.703
Average (Others) 0.734 0.708 0.686 0.717
Highest values for each allele are highlighted in bold.
doi:10.1371/journal.pone.0030483.t006
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and arginine (R) are at P6, which, as indicated by Figure 1, were
captured by TEPITOPEpan only. For DRB1*11:01, sequence
logos by TEPITOPEpan were relatively similar to those of
NetMHCIIpan-1.0 and NetMHCIIpan-2.0, particularly leucine
(L) at P4, arginine (R) and lysine (K) at P6 and serine (S) and alanine
(A) at P9, which were all consistent with the binding motif in
SYFPEITHI. Finally for DRB1*1201, a worth mentioning result is
that only TEPITOPEpansuggested valine(V)at P6,whichisclearly
consistent with the bindingmotif reported inSYFPEITHI database.
Overall the sequence logos showed unique characteristics of each
competing method, helping to understand the binding specificities
of various MHC alleles. For the four alleles, the sequence logos by
TEPITOPEpan demonstrated that they are consistent with known
binding motifs the most.
Evaluation by SYF-Set6 and EIEDB-Set7: Identifying HLA-
DR ligands and T-cell epitopes
Table 7 summarizes the results of comparison experiment on
SYF-Set6 for identifying HLA-DR ligands and EIEDB-Set7 for
detecting T-cell epitopes. For SYF-Set6, AUC was in the order of
NetMHCIIpan-2.0, TEPITOPEpan, NetMHCIIpan-1.0, and
MultiRTA for Avg per ligand, while for Avg per allele, the order
of AUC was NetMHCIIpan-2.0, NetMHCIIpan-1.0, TEPITO-
PEpan and MultiRTA. Interestingly, for EIEDB-Set7, the order of
Avg per epitope was the same as that of Avg per allele in SYF-
Set6, and that of Avg per allele was the same as that of Avg per
ligand in SYF-Set6. This indicates that the AUC of TEPITOPE-
pan was comparable against NetMHCIIpan-1.0, while these two
methods outperformed MultiRTA in EIEDB-Set7 (both per allele
and per epitope) and SYS-Set6 (per ligand), being statistically
significant (binomial test, p-value v0.05). Similarly note that
NetMHCIIpan-2.0 outperformed these three methods on both
datasets, being statistically significant (binomial test, p-value
v0.05), except NetMHCIIpan-1.0 on SYF-Set6. Thus we can
say that TEPITOPEpan is the second best method in identifying
HLA-DR ligands and T-cell epitopes.
For 20 alleles used by TEPITOPE, on both datasets, there were
no significant differences among TEPITOPEpan, NetMHCIIpan-
1.0, NetMHCIIpan-2.0 and TEPITOPE, all having outperformed
Figure 1. Comparing of different pan-specific methods by the sequence logos of peptides restricted to HLA-DRB1*04:02,
DRB1*11:01, DRB1*12:01, DRB1*13:01.
doi:10.1371/journal.pone.0030483.g001
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alleles, the AUC of TEPITOPEpan was lowered, and even
MultiRTA outperformed TEPITOPEpan for 9 out of 11 alleles in
SYF-Set6, being statistically significant (binomial test, p-
valuev0.05). Detailed results are shown in Table S2 and S3.
Evaluation by EpanCore-Set8: Identifying the binding
core
Table 8 shows the number of errors in predicting the binding
core of 20 known 3D complex structures in EpanCore-Set8. On
predicting the position of the binding core in a given sequence, if
the position was incorrect (not exact), we counted that prediction
as an error. This table shows that the number of errors by
TEPITOPEpan was the smallest among 4 competing methods
that can cover all HLA-DR alleles. We emphasize that
TEPITOPEpan achieved the smallest number, being better than
even NETMHCIIpan-2.0, implying that the predictive power of
TEPITOEpan would be comparable or might be better against
NETMHCIIpan-2.0 under the setting of not only giving a score to
a query peptide but also predicting the binding core exactly.
Detailed results are shown in Table S4.
Discussion
We have presented TEPITOPEpan that extends TEPITOPE to
predicting over 700 HLA-DR alleles with known sequences. Note
that TEPITOPEpan is simple, because of its PSSM-based nature.
Extensive experiments were conducted on a variety of datasets to
validate its performance. The summary of results showed that,
among the four methods in the benchmark, TEPITOPEpan
achieved roughly the second best performance in predicting
binding peptides of novel HLA-DR molecules and identifying
HLA-DR ligand and T-cell epitopes. In addition, TEPITOPEpan
achieved the best performance on identifying the bind core of a
given peptide. The most notable point is that TEPITOPEpan does
not need a large amount of training data which are usually
required for the other machine learning-based methods, but only
the sequence of a target allele.
The state-of-the-art pan-specific methods are generally based on
machine learning, requiring plenty of quantitative binding data.
Our experimental results demonstrate that their performances on
novel alleles do not necessarily reach a satisfactory level. It suggests
that trained models cannot be easily generalized to other alleles.
This may be due to several reasons. First, the design principles of
some pan-specific methods are oversimplified by which the
binding mechanism between MHC molecules and peptides cannot
be fully captured. Second, some pan-specific methods may be
overfitted to training alleles, and thus cannot achieve good
performance on novel alleles. Third, high-quality experimental
data are not enough for building an accurate pan-specific method.
Fourth, binding specificities of some novel alleles might be
different from those used for training the model. All these points
imply that improving existing pan-specific methods or developing
a more accurate method is vital for boosting the accuracy of pan-
specific MHC-II binding peptide prediction.
TEPITOPEpan was based on 35 unique binding specificity
vectors in TEPITOPE, which were obtained by biological
experiments on 11 HLA-DR alleles. Although the performance
of TEPITOPEpan has validated the reasonability of these vectors
in this paper, we still have to say that only 35 vectors are
insufficient. In fact, thousands of MHC class II molecules were
sequenced and many MHC-peptide complex structures have been
experimentally determined. A natural idea is to use the binding
specificities of new pockets of these MHC molecules by measuring
them using the state-of-the-art biochemical experiments. This
would make TEPITOPEpan achieve a higher performance.
Table 8. The number of errors on predicting binding cores of 20 complexes in EpanCore-Set8.
PDB #complexes #alleles NetMHCIIpan-2.0 NetMHCIIpan-1.0 MultiRTA TEPITOPEpan TEPITOPE
Count 20 7 5 errors 3 errors 3 errors 2 error 0 errors (2 missing)
The binding cores of 2 complexes cannot be predicted by TEPITOPE, since it doesn’t cover DRB3*01:01 and DRB3*02:01.
doi:10.1371/journal.pone.0030483.t008
Table 7. Evaluation on SYF-Set6 and EIEDB-SET7.
SYF-Set6 Ligand NetMHCIIpan-2.0 NetMHCIIpan-1.0 MultiRTA TEPITOPE TEPITOPEpan
Avg per ligand 1164 0.829 0.799 0.760 0.800
Avg per allele 28 0.797 0.787 0.756 0.769
Avg per allele (TEPITOPE alleles) 17 0.785 0.767 0.733 0.811 0.807
Avg per allele (Other alleles) 11 0.814 0.818 0.791 0.711
EIEDB-Set7 Epitope NetMHCIIpan-2.0 NetMHCIIpan-1.0 MultiRTA TEPITOPE TEPITOPEpan
Avg per epitope 1325 0.751 0.729 0.696 0.725
Avg per allele 42 0.781 0.759 0.717 0.762
Avg per allele (TEPITOPE alleles) 20 0.747 0.744 0.696 0.757 0.755
Avg per allele (Other alleles) 22 0.811 0.772 0.736 0.769
Identifying HLA-DR ligands and T-cell epitopes, respectively. Ligand and Epitopes show the number of HLA-DR ligands and HLA-DR epitopes, respectively. Avg per
ligand shows the average AUC over all ligands, and Avg per allele gives the average of Avg per ligand over all alleles.
doi:10.1371/journal.pone.0030483.t007
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prediction to other MHC-II alleles like HLA-DP, -DQ alleles and
even MHC-II alleles of non-human species.
Supporting Information
Figure S1 Comparing of different pan-specific methods
by the sequence logos of peptides restricted to HLA-
DRB1*01:02, DRB1*01:03, DRB1*03:02, DRB1*04:03,
DRB1*04:04, DRB1*04:05.
(PDF)
Figure S2 Comparing of different pan-specific methods
by the sequence logos based on sampled binding
peptides restricted to HLA-DRB1*08:13, HLA-
DRB1*11:02, DRB1*11:03, DRB1*11:04, DRB1*14:01,
DRB1*14:04.
(PDF)
Table S1 Composing residues of each pocket extracted
from 32 complex structures. The first column gives PDB IDs
of 32 MHC-II HLA-peptide complex structures from PDB. The
next 9 columns give extracted composing residues of nine pockets
of the HLA-DR molecule in the corresponding complex,
respectively. Each element,e.g. 82 N, consists of an index number
and the residue on that site. The last row gives a union set of
composing residue indexes.
(PDF)
Table S2 Evaluation of different methods on identifying
endogenous HLA-DR ligands from SYFPEITHI data-
base. Elements in the table are values of AUC and largest value
of each row is highlighted in bold. Predictions of NetMHCIIpan-
1.0 and 2.0 were obtained from their stand-alone packages.
Predictions of MultiRTA were from its web server. Count gives
the number of HLA-DR ligands retrieved from SYFPEITHI. Ave
per ligand gives the average AUC over all 1164 ligands. Ave per
allele gives the average of per-ligand-average AUCs of all alleles.
(PDF)
Table S3 Evaluation of different methods on identifying
HLA-DR T cell epitopes retrieved from IEDB. Elements in
the table are values of AUC and largest value of each row is
highlighted in bold. Predictions of NetMHCIIpan-1.0 and 2.0
were obtained from their standalone packages. Predictions of
MultiRTA were from its web server. Count gives the number of
HLA-DR epitopes retrieved from IEDB. Ave per epitope gives the
average AUC over all 1325 epitopes. Ave per allele gives an
average of per-epitope-average AUCs of all alleles.
(PDF)
Table S4 Evaluation on identifying binding core. The
table shows complexes with known binding cores retrieved from
PDB. The first two columns in the table give PDB ID, HLA-DR
restriction, bound peptide and experimentally determined binding
core, respectively. Twenty distinct structures in terms of allele and
peptide sequence are labeled with an asterisk. The last columns
give predicted cores of different methods. Predictions of different
methods were obtained from their stand-alone packages or web
servers. Prediction results based on 20 distinct structures are
shown in brackets with an asterisk. Additionally, TEPITOPE can
not make prediction for DRB3*01:01 and DRB3*02:01.
(PDF)
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